admin
India
healthysoch
New Delhi, June 01, 2021 :
Sir Ganga Ram Hospital has commenced administration of Monoclonal Antibody Cocktail (MAC) from 01 June 2021, a combination of Casirivimab & Imdevimab to consenting patients with mild & moderate Covid-19 symptoms at high risk of developing serious illness. As per Drug Controller General of India (DCGI), selection of patients will entail that they:
(A) have Covid-19 Positive test report.
(B) have mild to moderate Covid disease.
(C) are in the age group of 12 & above and weighing at least 40Kg.
(D) are at high risk of Covid-19.
The MRP of one MAC dose for a patient will be Rs. 59,750/- only.
According to Dr. D.S. Rana, Chairman (BOM), Sir Ganga Ram Hospital said, “As per the claims of the company Roche/ Cipla we hope MAC will be a major factor in fight against Covid-19 to prevent disease from progressing to further severity”.
healthysoch
